About Hancock Jaffe Laboratories, Inc. Warrants (HJLIW) — Dividend Analysis 2026
HJLIW is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in HJLIW shares.
Is HJLIW a good dividend investment in 2026?
HJLIW offers a 357.14% forward yield with a 50% payout ratio. Strand Safety Score: 30/100 (High Risk). The 5-year dividend CAGR of 0% is modest — investors should weigh current income against growth alternatives.
HJLIW DRIP calculator — what's the difference?
With DRIP on a $10,000 investment over 10 years, your HJLIW portfolio grows to $39858.36M vs $367.1K without reinvestment. This is the compound interest effect in action.
HJLIW dividend growth history & forecast
HJLIW has grown its dividend by 0% over the last year and 0% annually over 5 years. At this pace, an investor who holds for 10+ years will see their yield on cost grow substantially above the current 357.14%.
Company generates negative FCF ($-16M) — borrowing to pay dividends
Debt Leverage0.0× Debt/EBITDA
0 / 30 pts
0/30
Company not generating EBITDA — debt servicing risk is elevated
Earnings Momentum-0.0B → -0.0B → -0.0B
30 / 30 pts
30/30
Net income grew for 2 consecutive years — strong earnings momentum
OVERALL ASSESSMENT
Dividend sustainability questionable — consider alternative income stocks.
STRAND SCORE
30
/100
Strand Safety Score™ is proprietary to DividendFlow. Inputs: FCF, Debt/EBITDA, Net Income from SEC filings via FMP. Not financial advice. N/A for ETFs, pre-revenue companies, and tickers without income statements.
🌍 HJLIW Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold HJLIW.
Gross yield
357.14%
Tax rate
15.00%
After-tax yield
303.57%
Real yield (−CPI)
300.77%
Account/Country
Tax Rate
After-tax Yield
Real Yield
$10K Annual Income
🇺🇸 Roth IRA / 401k
0%
357.14%
354.34%
$35,714 / yr
🇺🇸 US Taxable (15%) ✓
15%
303.57%
300.77%
$30,357 / yr
🇺🇸 US Taxable (20%)
20%
285.71%
282.91%
$28,571 / yr
🇬🇧 UK ISA
0%
357.14%
354.34%
$35,714 / yr
🇬🇧 UK Taxable
8.75%
325.89%
323.09%
$32,589 / yr
🇨🇦 TFSA
0%
357.14%
354.34%
$35,714 / yr
🇨🇦 CA Taxable
25%
267.86%
265.06%
$26,786 / yr
🇦🇺 Super (pension)
15%
303.57%
300.77%
$30,357 / yr
🇦🇺 AU Taxable
30%
250.00%
247.20%
$25,000 / yr
🇩🇪 DE Taxable
26.375%
262.94%
260.14%
$26,294 / yr
🇫🇷 FR Taxable
30%
250.00%
247.20%
$25,000 / yr
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 HJLIW Income Goal & Break-Even
Dividend Break-Even
1yr
Years for dividends to fully repay your HJLIW investment of $0.56/share (🇺🇸 US Taxable (15%) · 15.00% tax)
$10K invested · 10 Years
Dividends earned (DRIP)
$11460.50M
Lost to inflation (2.8% CPI)
−$2.5K
Real purchasing power gain
$11460.50M
12-month CPI (US BLS via FMP economic-indicators).
How much do I need to invest in HJLIW for:
Shares needed
14,118
Capital required
$7,906
Monthly income
$2,000
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 HJLIW Dividend Payment Schedule
HJLIW pays quarterly — 4 times per year. Next ex-div: TBD.
Jan
Feb
Mar
💰
Apr
May
Jun
💰
Jul
Aug
Sep
💰
Oct
Nov
Dec
💰
10 shares
$4.25 / payment
$17.00 / year after tax
100 shares
$42.50 / payment
$170.00 / year after tax
1,000 shares
$425.00 / payment
$1700.00 / year after tax
📊 HJLIW vs Healthcare Benchmarks
How HJLIW compares to typical Healthcare averages.
Benchmark: Healthcare
Dividend Yield▲+354.34% vs sectorBetter
HJLIW
357.14%
avg
2.80%
5Y Dividend CAGR▼-6.80% vs sectorBelow avg
HJLIW
0.00%
avg
6.80%
Payout Ratio▲-5.00% vs sectorBetter
HJLIW
50.00%
avg
55.00%
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for HJLIW sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ HJLIW Insider Activity
▼ 3 Sales
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
Insider
Title
Type
Date
Shares
Price
Total Value
Duhay Francis
director
Sale
2026-03-12
140
$11.52
$1.6K
BERMAN ROBERT ANDREW
director, officer: Chief Executive Officer
J-Other
2025-12-16
200,000
—
—
Alavi Hamed
officer: Chief Technology Officer
J-Other
2025-12-16
50,000
—
—
Glickman Marc H.
officer: SVP & Chief Medical Officer
J-Other
2025-12-16
100,000
—
—
Duhay Francis
director
A-Award
2025-12-11
135,883
$0.33
$44.2K
Gray Robert
director
A-Award
2025-12-11
135,883
$0.33
$44.2K
Jenusaitis Matthew
director
A-Award
2025-12-11
135,883
$0.33
$44.2K
Shrivastava Sanjay
director
A-Award
2025-12-11
135,883
$0.33
$44.2K
Duhay Francis
director
Sale
2025-12-11
4,900
$0.36
$1.7K
Duhay Francis
director
Sale
2025-09-15
4,900
$0.83
$4.1K
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
🔬
Financial Health Scores
Altman Z-Score
-8.02
🔴 Distress Zone — elevated dividend cut risk
Safe: >3.0 · Grey: 1.81–3.0 · Distress: <1.81
Piotroski F-Score
3/9
🔴 Weak fundamentals — dividend safety concern
Strong: 7–9 · Moderate: 4–6 · Weak: 0–3
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
🟡
Net Insider Sentiment: Neutral0 buys · 1 sells · last 90 days
Net: $-1613.00
📊 About This Data
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the HJLIW dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →